← Back to Search
Impact Of Age At Diagnosis On Prostate Cancer Treatment And Survival.
Seth K. Bechis, P. Carroll, Matthew R. Cooperberg
Published 2011 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
PURPOSE Older men are more likely to be diagnosed with high-risk prostate cancer and to have lower overall survival. As a result, age often plays a role in treatment choice. However, the relationships among age, disease risk, and prostate cancer-specific survival have not been well established. PATIENTS AND METHODS We studied men in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) database with complete risk, treatment, and follow-up information. High-risk patients were identified by using the validated Cancer of the Prostate Risk Assessment (CAPRA) score. Competing risks regression was used to identify the independent impact of age on cancer-specific survival. We also analyzed the effect of local treatment on survival among older men with high-risk disease. RESULTS In all, 26% of men age ≥ 75 years presented with high-risk disease (CAPRA score 6 to 10). Treatment varied markedly with age across risk strata; older men were more likely to receive androgen deprivation monotherapy. Controlling for treatment modality alone, or for treatment and risk, age did not independently predict cancer-specific survival. Furthermore, controlling for age, comorbidity, and risk, older men with high-risk tumors receiving local therapy had a 46% reduction in mortality compared with those treated conservatively. CONCLUSION Older patients are more likely to have high-risk prostate cancer at diagnosis and less likely to receive local therapy. Indeed, underuse of potentially curative local therapy among older men with high-risk disease may in part explain observed differences in cancer-specific survival across age strata. These findings support making decisions regarding treatment on the basis of disease risk and life expectancy rather than on chronologic age.
This paper references
Continued undertreatment of older men with localized prostate cancer.
K. Schwartz (2003)
30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
S. Alibhai (2005)
Management of localized prostate cancer in senior adults: the crucial role of comorbidity
J. Fitzpatrick (2008)
Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE.
Paige L Marr (2006)
Time trends and local variation in primary treatment of localized prostate cancer.
M. Cooperberg (2010)
Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist.
V. Shahinian (2006)
Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE.
B. Konety (2008)
Outcomes of localized prostate cancer following conservative management.
G. Lu-Yao (2009)
Adverse events associated with hormonal therapy for prostate cancer.
R. Kumar (2005)
A Proportional Hazards Model for the Subdistribution of a Competing Risk
J. Fine (1999)
Prostate cancer in elderly men.
A. Stangelberger (2008)
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
V. Moyer (2012)
Differences between urologists in the United States and Canada in the approach to prostate cancer.
N. Fleshner (2000)
Prostate cancer in the elderly.
H. Heinzer (2009)
Mortality results from a randomized prostate-cancer screening trial.
G. Andriole (2009)
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.
M. Kattan (1998)
Survival after the age of 80 in the United States, Sweden, France, England, and Japan.
K. Manton (1995)
Radical prostatectomy in men aged ≥70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram
L. Richstone (2008)
Robot‐assisted radical prostatectomy in men aged ≥70 years
K. Greco (2009)
Epidemiology of prostate cancer.
E. Crawford (2003)
Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association.
R. Middleton (1995)
Deaths: preliminary data for 2011.
D. Hoyert (2012)
Do older men benefit from curative therapy of localized prostate cancer?
S. Alibhai (2003)
Comparative risk‐adjusted mortality outcomes after primary surgery, radiotherapy, or androgen‐deprivation therapy for localized prostate cancer
M. Cooperberg (2010)
The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor.
D. Lubeck (1996)
Treatments for prostate cancer in older men: 1984-1997.
T. Bubolz (2001)
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer
A. Kibel (2007)
Cancer Statistics, 2010
A. Jemal (2010)
Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening?
Ned Calonge (2009)
Cause of Death in Older Men After the Diagnosis of Prostate Cancer
Melanie Ketchandji (2009)
Analysis of treatment practices for elderly cancer patients in Ontario, Canada.
C. Townsley (2005)
The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.
M. Cooperberg (2004)
Physician visits prior to treatment for clinically localized prostate cancer.
T. Jang (2010)
Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.
M. Cooperberg (2009)
Clinicians are poor raters of life‐expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer
Jochen Walz (2007)
Deaths: preliminary data for 2000.
A. Miniño (2001)
Are age-based criteria the best way to determine eligibility for prostate cancer screening?
B. Konety (2009)
The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
M. Cooperberg (2004)
Erratum: Comparative risk‐adjusted mortality outcomes after primary surgery, radiotherapy, or androgen‐deprivation therapy for localized prostate cancer
Matthew R. Cooperberg (2011)
Comparative risk-adjusted mortality outcomes following primary surgery , radiation therapy , or androgen deprivation therapy for localized prostate cancer
M. Cooperberg (2011)
Prostate cancer in the elderly
E. Scosyrev (2012)
PSA Screening Among Elderly Men With Limited Life Expectancies
P. Loehrer (2008)
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy
Jochen Walz (2008)
Screening and Prostate-Cancer Mortality in a Randomized European Study
A. Kibel (2009)
Primary treatment choices for men with clinically localized prostate carcinoma detected by screening
Y. Yan (2000)
This paper is referenced by
Nationally-representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America Project
K. Cary (2015)
PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation? Opinion: No
J. Clavell-Hernández (2017)
Cancer de prostate des sujets âgés : place et rôle de l’évaluation gériatrique
Benoîte Méry (2016)
Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease
J. Tosoian (2017)
Risk Factors for Cancer-specific Mortality and Cardiovascular Mortality in Patients With Diffuse Large B-cell Lymphoma.
J. Zhao (2020)
Reply to G. Gandaglia et al and K. Lu.
D. Shumway (2015)
Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with Prostate Cancer Treated with Radical Prostatectomy.
K. Boehm (2016)
Late-Stage Prostate Cancer and Prostate Cancer Mortality : A Population-Based Study
Sven Löffeler (2019)
Progress in management of low-risk prostate cancer: how registries may change the world.
M. Cooperberg (2015)
Patients aged more than 70 had higher risk of locally advanced prostate cancers and biochemical recurrence in Korea
J. Kim (2012)
NCCN Guidelines Version 2 . 2015 Table of Contents Prostate Cancer Early Detection
Peter R. Carroll (2015)
Epidemiology of prostate cancer: current status.
Z-Q Tao (2015)
Determining the Natural History of Men with Initially Negative Prostate Biopsies
R. Sayyid (2017)
Prostate-specific antigen (PSA) rate of decline post external beam radiotherapy predicts prostate cancer death.
Zumin Shi (2013)
Experience with age discrimination and attitudes toward ageism in older patients with cancer and their caregivers: A nationwide Korean survey.
D. Shin (2019)
Impact of age on quality of life in patients with localized prostate cancer treated with high‐dose rate brachytherapy combined with external beam radiotherapy
K. Kikkawa (2018)
Orgasmic Dysfunction Following Radical Prostatectomy: Review of Current Literature.
J. Clavell-Hernández (2018)
The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages
S. Knipper (2020)
Radical Treatment for Localized Disease: An Overview of Options and Strategies for Decision Making
J. A. Smith (2013)
Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.
M. Cooperberg (2015)
Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults
Hui Guo (2017)
Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity.
K. Hoffman (2012)
Patient Selection for Active Surveillance
J. Eifler (2012)
Title Sixth joint meeting of J-Cap and CaPSURE-A multinational perspective on prostate cancer management and patient outcomes Permalink
H. Akaza (2013)
Active Surveillance in Younger Men With Prostate Cancer.
M. Leapman (2017)
Prostate Gland and Related Disorders
N. Nagaratnam (2017)
Medical innovation, education, and labor market outcomes of cancer patients.
Sung-hee Jeon (2019)
Definitive Radiation Treatment Patterns and Outcomes for Low and Intermediate Risk Prostate Cancer Patients
F. Asamoah (2019)
Aktive Überwachung beim Niedrig-Risiko-Prostatakarzinom
A. Herlemann (2015)
Aging Men and Prostate Cancer
J. Reproduktionsmed (2018)
Prostate Cancer Early Detection, Version 2.2015
P. Carroll (2015)
Discordant Interpretations of Breast Biopsy Specimens by Pathologists--Reply.
J. Elmore (2015)See more